Journal:JMB:1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 9: Line 9:
Cyt1Aa <font color='lime'><b>(lime)</b></font>, like other Cyt family members, also has a <scene name='Journal:JMB:1/Cv/8'>fold similar to that of the toxic Volvatoxin (VVA2)</scene> (<font color='cyan'><b>cyan</b></font>, PDB code [[1vcy]]) and the non-toxic virulence factor Evf (PDB code [[2w3y]]) despite their very low sequence identity. While, Evf is covalently bound to palmitate, none of the Cyt family members contain a palmitoylated Cys residue. The structural homology between Cyt1Aa and Evf enabled the identification of a <scene name='Journal:JMB:1/Cv/10'>putative fatty acid binding site in Cyt1Aa between the sheet formed by beta4, beta6-beta8 and helices alpha3-alpha5</scene>. The Cyt1Aa structure displays the <scene name='Journal:JMB:1/Cv/13'>conserved hydrophobic residues</scene> <font color='magenta'><b>(colored in magenta)</b></font> pointing towards the putative lipid-binding pocket. We suggest that in Evf, the covalently bound lipid “locks” the helical layer to the &#946;-sheet and prevents the conformational changes necessary for membrane insertion, explaining its observed non-toxicity. On the other hand, the absence of the lipid in Cyt1Aa enables its flexibility and allows the conformational changes of the two surrounding &#945;-helical layers of Cyt1Aa necessary for exposing the hydrophobic &#946;-sheet which is necessary prior to their membrane insertion and perforation.
Cyt1Aa <font color='lime'><b>(lime)</b></font>, like other Cyt family members, also has a <scene name='Journal:JMB:1/Cv/8'>fold similar to that of the toxic Volvatoxin (VVA2)</scene> (<font color='cyan'><b>cyan</b></font>, PDB code [[1vcy]]) and the non-toxic virulence factor Evf (PDB code [[2w3y]]) despite their very low sequence identity. While, Evf is covalently bound to palmitate, none of the Cyt family members contain a palmitoylated Cys residue. The structural homology between Cyt1Aa and Evf enabled the identification of a <scene name='Journal:JMB:1/Cv/10'>putative fatty acid binding site in Cyt1Aa between the sheet formed by beta4, beta6-beta8 and helices alpha3-alpha5</scene>. The Cyt1Aa structure displays the <scene name='Journal:JMB:1/Cv/13'>conserved hydrophobic residues</scene> <font color='magenta'><b>(colored in magenta)</b></font> pointing towards the putative lipid-binding pocket. We suggest that in Evf, the covalently bound lipid “locks” the helical layer to the &#946;-sheet and prevents the conformational changes necessary for membrane insertion, explaining its observed non-toxicity. On the other hand, the absence of the lipid in Cyt1Aa enables its flexibility and allows the conformational changes of the two surrounding &#945;-helical layers of Cyt1Aa necessary for exposing the hydrophobic &#946;-sheet which is necessary prior to their membrane insertion and perforation.
In attempt to understand why Cyt1Ca is non-toxic, we performed a comparative sequence analysis of all known Cyt1 family members revealing that Cyt1Ca is the most divergent. The residues that are conserved in Cyt1Aa, Cyt1Ab and Cyt1Ba but differ in Cyt1Ca are located on the &#945;-helical layers and on strands &#946;1, &#946;4 and &#946;5 which have been proposed to undergo conformational changes upon membrane binding. The contribution of these residues to the lack of toxicity of Cyt1Ca was supported by the finding that mutating three of these non-conserved residues, Q154, Q164, and G240 in Cyt1Ca to the corresponding charged and exposed residues in Cyt1Aa, K154, E164, and D240 respectively, restored partial antibacterial though not larvicidal activities indicating their importance. We suggest that the lack of its toxicity may also be related to its lack of flexibility. This is supported by the finding that substitution of Q225 in Cyt1Ca to the corresponding conserved K225 in Cyt1Aa, does not restore activity. This residue is located on &#946;8, which is part of the sheet thought to insert into the membrane. We postulate that the location of the non-conserved residues in Cyt1Ca may render this protein unable to undergo the conformational changes associated with membrane insertion, thereby explaining its non-toxicity.
In attempt to understand why Cyt1Ca is non-toxic, we performed a comparative sequence analysis of all known Cyt1 family members revealing that Cyt1Ca is the most divergent. The residues that are conserved in Cyt1Aa, Cyt1Ab and Cyt1Ba but differ in Cyt1Ca are located on the &#945;-helical layers and on strands &#946;1, &#946;4 and &#946;5 which have been proposed to undergo conformational changes upon membrane binding. The contribution of these residues to the lack of toxicity of Cyt1Ca was supported by the finding that mutating three of these non-conserved residues, Q154, Q164, and G240 in Cyt1Ca to the corresponding charged and exposed residues in Cyt1Aa, K154, E164, and D240 respectively, restored partial antibacterial though not larvicidal activities indicating their importance. We suggest that the lack of its toxicity may also be related to its lack of flexibility. This is supported by the finding that substitution of Q225 in Cyt1Ca to the corresponding conserved K225 in Cyt1Aa, does not restore activity. This residue is located on &#946;8, which is part of the sheet thought to insert into the membrane. We postulate that the location of the non-conserved residues in Cyt1Ca may render this protein unable to undergo the conformational changes associated with membrane insertion, thereby explaining its non-toxicity.
-
Cyt1Aa synergizes activities of Cry11Aa. Two binding epitopes of Cyt1Aa, <scene name='Journal:JMB:1/Cv1/1'>196-EIKVSAVKE-204</scene> (locating on &#946;7 and &#945;6) and 220-NIQSLKFAQ-228 (locating on &#946;8) (Figure 1), were found to be involved in the binding interaction with Cry11Aa. Both regions are mostly embedded, with only 200-SAVKE-204 exposed. The role of these epitopes was confirmed by heterologous competition assays using synthetic peptides. corresponding to these regions and by site directed mutagenesis. In particular, three single residues, K198, E204 and K225 within these two segments were shown to be involved in the interaction between these two proteins which in turn explain the synergism between them. Recently it has been shown that mutation of these Cyt1Aa residues affect its binding and synergism with Cry4Ba as well. Interestingly, these three residues are charged in most of the Cyt1 family members, whereas in the Cyt2 family and in Cyt1Ca, which presumably do not bind Cry11Aa, they are polar (T198, Q204 and T225 respectively in Cyt2Ba). Thus, it seems reasonable that synergism and binding of Cyt1Aa to Cry11Aa or to Cry4Ba depend on specific interactions between these toxins, which involve these residues. We suggest that the reduced charge on the Cyt2 protein members and on Cyt1Ca may be sufficient to abrogate binding to Cry11Aa. It was suggested that mutating these residues in other Cyt proteins to the corresponding Cyt1Aa charged residues might introduce binding sites and induce synergism with Cry toxins. This strategy could be used as a tool to overcome Cry-resistance in the midgut membrane of resistant insects.A sequential mechanism has been proposed by which Cyt1Aa initially undergoes conformational changes to insert its &#946;-sheet into the membrane following binding of Cry11Aa via the two Cyt1Aa binding epitopes resulting in insertion of Cry11Aa into the mosquito membranes. Mapping the three charged residues on the Cyt1Aa structure (Figure 3) revealed that while all three residues are exposed to the surface of the protein, they all reside on regions of the toxin which presumably are inserted into the membrane (K198 and E204 are located on &#946;7 and &#945;6, and K225 is part of &#946;8). We therefore, can't out rule an alternative mechanism by which Cyt1Aa binds Cry11Aa using these exposed charged residues prior to its membrane insertion. Thus, the action of Cyt1Aa alone or as a receptor for Cry11Aa may involve different mechanisms.
+
Cyt1Aa synergizes activities of Cry11Aa. Two binding epitopes of Cyt1Aa, <scene name='Journal:JMB:1/Cv1/1'>196-EIKVSAVKE-204</scene> (locating on &#946;7 and &#945;6) and <scene name='Journal:JMB:1/Cv1/2'>220-NIQSLKFAQ-228</scene> (locating on &#946;8), were found to be involved in the binding interaction with Cry11Aa. Both regions are mostly embedded, with only 200-SAVKE-204 exposed. The role of these epitopes was confirmed by heterologous competition assays using synthetic peptides. corresponding to these regions and by site directed mutagenesis. In particular, three single residues, K198, E204 and K225 within these two segments were shown to be involved in the interaction between these two proteins which in turn explain the synergism between them. Recently it has been shown that mutation of these Cyt1Aa residues affect its binding and synergism with Cry4Ba as well. Interestingly, these three residues are charged in most of the Cyt1 family members, whereas in the Cyt2 family and in Cyt1Ca, which presumably do not bind Cry11Aa, they are polar (T198, Q204 and T225 respectively in Cyt2Ba). Thus, it seems reasonable that synergism and binding of Cyt1Aa to Cry11Aa or to Cry4Ba depend on specific interactions between these toxins, which involve these residues. We suggest that the reduced charge on the Cyt2 protein members and on Cyt1Ca may be sufficient to abrogate binding to Cry11Aa. It was suggested that mutating these residues in other Cyt proteins to the corresponding Cyt1Aa charged residues might introduce binding sites and induce synergism with Cry toxins. This strategy could be used as a tool to overcome Cry-resistance in the midgut membrane of resistant insects.A sequential mechanism has been proposed by which Cyt1Aa initially undergoes conformational changes to insert its &#946;-sheet into the membrane following binding of Cry11Aa via the two Cyt1Aa binding epitopes resulting in insertion of Cry11Aa into the mosquito membranes. Mapping the three charged residues on the Cyt1Aa structure (Figure 3) revealed that while all three residues are exposed to the surface of the protein, they all reside on regions of the toxin which presumably are inserted into the membrane (K198 and E204 are located on &#946;7 and &#945;6, and K225 is part of &#946;8). We therefore, can't out rule an alternative mechanism by which Cyt1Aa binds Cry11Aa using these exposed charged residues prior to its membrane insertion. Thus, the action of Cyt1Aa alone or as a receptor for Cry11Aa may involve different mechanisms.
The pattern of the hemolytic activity of Cyt1Aa presented here (resembling that of pore-forming agents), while differing from that imposed by ionic and nonionic detergents, further supports the pore-forming model by which conformational changes occur prior to membrane insertion and perforation.
The pattern of the hemolytic activity of Cyt1Aa presented here (resembling that of pore-forming agents), while differing from that imposed by ionic and nonionic detergents, further supports the pore-forming model by which conformational changes occur prior to membrane insertion and perforation.

Revision as of 11:45, 6 October 2011

Drag the structure with the mouse to rotate


  1. Cohen S, Albeck S, Ben-Dov E, Cahan R, Firer M, Zaritsky A, Dym O. Cyt1Aa Toxin: High-Resolution Structure Reveals Implications for Its Membrane-Perforating Function. J Mol Biol. 2011 Sep 19. PMID:21959261 doi:10.1016/j.jmb.2011.09.021

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools